Alice Hall-Partyka

Partner | She/Her/Hers

Overview

Alice Hall-Partyka counsels payers, providers, and technology companies on a broad range of health care regulatory, corporate, and policy matters. Alice uses her industry experience to help clients identify practical solutions and navigate complex regulatory frameworks.

Alice advises health care companies that are adapting to evolving laws and regulations, developing new products or services, or seeking to improve their regulatory compliance. She also strategizes with and represents clients that are responding to governmental inquiries and investigations. Alice’s areas of focus include Medicaid and Medicare program requirements, mental health parity, health reform, state regulation of payers and providers, digital health and innovative technologies, and health care fraud and abuse.

Alice applies her knowledge of the regulatory landscape while supporting health care companies with corporate and transactional matters. She regularly negotiates health care transactions, including management services agreements, data use agreements, pharmacy benefit management contracts, and innovative care delivery arrangements. Further, Alice addresses the legal questions that arise in day-to-day provider and payer operations in areas ranging from licensing to structuring and corporate governance.

Alice maintains an active pro bono practice, through which she has represented asylum and Special Immigrant Juvenile Status applicants, handled appellate matters relating to racial justice and environmental protection, and formed and advised a nonprofit organization focused on health equity and health literacy. Alice was named Volunteer of the Year in 2022 by the Inland Counties Legal Services, a legal aid nonprofit in the Inland Empire working to close the justice gap.

While in law school, Alice successfully represented a client who was in asylum removal proceedings and served as the student director of the Afghanistan Legal Education Project, an initiative funded by the U.S. Department of State.

Career & Education

    • University of Southern California, B.A., summa cum laude, Phi Beta Kappa, Environmental Studies, 2014
    • University of Southern California, B.S., summa cum laude, Phi Beta Kappa, Global Health, 2014
    • Stanford Law School, J.D., High Pro Bono Distinction, 2017
    • University of Southern California, B.A., summa cum laude, Phi Beta Kappa, Environmental Studies, 2014
    • University of Southern California, B.S., summa cum laude, Phi Beta Kappa, Global Health, 2014
    • Stanford Law School, J.D., High Pro Bono Distinction, 2017
    • California
    • California

Alice's Insights

Client Alert | 3 min read | 10.17.25

California Enacts New Requirements and Restrictions for Health Care Transactions

California recently enacted two laws instituting new restrictions and requirements for health care transactions. On October 6, Governor Newsom signed SB 351, which codifies elements of the state’s corporate practice of medicine doctrine and strengthens restrictions against private equity, hedge fund, and other private investor control of health care organizations and operations. On October 11, Newsom signed AB 1415, which expands the scope of parties and relevant transactions that require pre-transaction notice to the state’s Office of Health Care Affordability (OHCA). Both laws are intended to provide the State of California greater oversight of transactions involving health care entities, and raise additional hurdles for parties seeking to acquire or sell health care operations in the state,[1] consistent with a broader trend across the country. The key points of each of the California laws are summarized below:...

Recognition

  • Inland Counties Legal Services: Volunteer of the Year, 2022

Alice's Insights

Client Alert | 3 min read | 10.17.25

California Enacts New Requirements and Restrictions for Health Care Transactions

California recently enacted two laws instituting new restrictions and requirements for health care transactions. On October 6, Governor Newsom signed SB 351, which codifies elements of the state’s corporate practice of medicine doctrine and strengthens restrictions against private equity, hedge fund, and other private investor control of health care organizations and operations. On October 11, Newsom signed AB 1415, which expands the scope of parties and relevant transactions that require pre-transaction notice to the state’s Office of Health Care Affordability (OHCA). Both laws are intended to provide the State of California greater oversight of transactions involving health care entities, and raise additional hurdles for parties seeking to acquire or sell health care operations in the state,[1] consistent with a broader trend across the country. The key points of each of the California laws are summarized below:...

Alice's Insights

Client Alert | 3 min read | 10.17.25

California Enacts New Requirements and Restrictions for Health Care Transactions

California recently enacted two laws instituting new restrictions and requirements for health care transactions. On October 6, Governor Newsom signed SB 351, which codifies elements of the state’s corporate practice of medicine doctrine and strengthens restrictions against private equity, hedge fund, and other private investor control of health care organizations and operations. On October 11, Newsom signed AB 1415, which expands the scope of parties and relevant transactions that require pre-transaction notice to the state’s Office of Health Care Affordability (OHCA). Both laws are intended to provide the State of California greater oversight of transactions involving health care entities, and raise additional hurdles for parties seeking to acquire or sell health care operations in the state,[1] consistent with a broader trend across the country. The key points of each of the California laws are summarized below:...